Total Reports
7
FDA CVM filings
Horse /
FDA CVM · 2025 release 7 reports on file
Lippizzaner - FDA Adverse Event Profile
Adverse-event records for Lippizzaner (Horse) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Among horse breeds, Lippizzaner is #463 by FDA report volume; 42.9% of its 7 reports (3) were death-coded.
- #463
- most-reported horse breed
- 42.9%
- death-coded report share
- 3
- Death by euthanasia - top reaction
- 19.7 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
3
of 7 reports
Death Rate
42.9%
death-coded share
Avg Age at Report
19.7 yr
484.2 kg avg weight
Death-Coded Outcome Share
Lippizzaner death-coded reports 42.9%
Cross-breed median
42.9% of 7 lippizzaner reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 484.2 kg (1067.7 lbs)
Top Reported Reactions
Death by euthanasia 3
INEFFECTIVE, SEDATION 2
Laminitis 1
Decreased appetite 1
Ataxia 1
Most Referenced Drugs
Pergolide Mesylate 3
Praziquantel; Moxidectin 1
Ketamine Hydrochloride 1
Xylazine 1
Oxybendazole 1
Outcome Breakdown
Outcome Unknown
3 (42.9%)
Euthanized
3 (42.9%)
Recovered/Normal
1 (14.3%)
Gender Distribution
Male 4 (57.1%)
Female 2 (28.6%)
Unknown 1 (14.3%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2013 | 1 | |
| 2014 | 1 | |
| 2015 | 1 | |
| 2017 | 2 | |
| 2021 | 1 | |
| 2023 | 1 | |
Lippizzaner Pet Health Insights
Lippizzaner accounts for 7 FDA adverse event reports, ranking #463 by volume among horse breeds, with 3 reports (42.9%) coded as a death outcome. Mean age at report: 19.7 years, average weight 484.2 kg (1067.7 lbs).
Top reported signs: Death by euthanasia (3), INEFFECTIVE, SEDATION (2), Laminitis (1). Most-referenced drug: Pergolide Mesylate (3 reports), followed by Praziquantel; Moxidectin (1) and Ketamine Hydrochloride (1).
Outcome coding on 7 status-recorded reports is dominated by Outcome Unknown (42.9%). Annual submissions ranged 2,013-2,023 across 6 years on file.
Horse Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Lippizzaner? ▼
There are 7 adverse event reports involving Lippizzaner in the FDA database, with 3 reports involving death (42.9% death rate). Lippizzaner ranks #463 by report volume.
What are the most common adverse reactions reported for Lippizzaner? ▼
The most commonly reported adverse reactions for Lippizzaner are Death by euthanasia (3 reports), INEFFECTIVE, SEDATION (2 reports), Laminitis (1 reports), Decreased appetite (1 reports), Ataxia (1 reports).
What drugs are most frequently associated with Lippizzaner adverse events? ▼
The drugs most frequently referenced in Lippizzaner adverse event reports are Pergolide Mesylate (3 reports), Praziquantel; Moxidectin (1 reports), Ketamine Hydrochloride (1 reports), Xylazine (1 reports), Oxybendazole (1 reports).
What is the average age of Lippizzaner in adverse event reports? ▼
The average age of Lippizzaner at the time of adverse event reports is 19.7 years, with an average weight of 484.2 kg (1067.7 lbs).
Does a high number of adverse event reports mean Lippizzaner is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Lippizzaner safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.